To find early clinical markers that may predict a likely progression to Alzheimer’s disease (AD), the authors performed neuropsychological tests on 82 mild cognitive impairment (MCI) subjects. After 3 years, 38 patients developed AD while 44 retained the diagnosis of MCI. The cognitive differences between the groups were studied. Patients who developed AD showed significantly lower values than did MCI subjects in some neuropsychological scores (P = .02-.001), with sensitivities and specificities higher than 84% and 64%, respectively, for detecting early-onset AD, with a 7.9-fold increased risk of converting to AD (P < .001). Regarding the logistic regression model, the CAMCOG Memory and Perception cognitive screening items were the optimum independent tools to classify the patients who will progress to AD, showing a relative risk of progression of 10.5 (P = .002), 5.5 (P = .008), and 3.9 times (P = .05), respectively, with a sensibility of of 92.1% and a specificity 72.7%.
Petersen RC, Stevens JC, Gangly M, et al.Early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001; 56:1133-1142.
2.
Petersen RC, Dowdy R, Kurtz A, et al.Current concepts in mild cognitive impairment. Arch Neurol. 2001;58: 1985-1992.
3.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.Washington, DC, American Psychiatric Association; 1994.
4.
World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders. Geneva, Switzerland: World Health Organization; 1992.
5.
Robles A, Del Ser T, Alum J, et al.Prophets de criterions Para el diagnóstico clínico del deteriorate cognitive liger, la dementia y la enfermedad de Alzheimer. Neurología. 2002;17(1):17-32.
6.
Ritchie K, Artero S, Touchon J.Classification criteria for mild cognitive impairment: a population-based validation study. Neurology. 2001;56:37-42.
7.
Amieva H, Letenneur L, Dartigues JF, et al.Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study. Dement Geriatr Cogn Disord. 2004;18:87-93.
8.
Petersen RC, Smith GE, Waring SC, et al.Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
9.
Bennett DA, Wilson RS, Schneider JA, et al.Natural history of mild cognitive impairment in older persons. Neurology. 2002;59:198-205.
10.
Schofield PW, Marder K, Doonieief G, et al.Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment. Am J Psychiatry. 1997;154: 609-615.
11.
Johansson B, Zarit SH.Early cognitive markers of the incidence of dementia and mortality: a longitudinal study of the oldest old. Int J Geriatr Psychiatry. 1997;12:53-59.
Hogan DB, Ebly EM.Predicting who will develop dementia in a cohort of Canadian seniors. Can J Neurol Sci. 2000;27: 18-24.
14.
Tierney MC, Szalai JP, Snow WG, et al.Prediction of probable Alzheimer’s disease in memory-impaired patients: a prospective longitudinal study. Neurology. 1996;46:661-665.
15.
Morris JC, Storandt M, Phillip JP, et al.Mild cognitive impairment represents early-stage Alzheimer’s disease. Arch Neurol. 2001;58:397-405.
16.
Bozoki A, Giordani B, Heidebrink JL, et al.Mild cognitive impairment predicts dementia in non-demented elderly patients with memory loss. Arch Neurol. 2001;58:411-416.
17.
Christiansen H, Henderson AS, Korten AE, et al.ICD- 10 mild cognitive disorder: its outcome three years later. Int Geriatr Psychiatry. 1997;12:581-586.
18.
Daly E, Zaithchik D, Copeland M, et al.Predicting conversion to Alzheimer’s disease using standardized clinical information. Arch Neurol. 2000;57:675-680.
19.
Palmer K, Wang H, Backman L, et al.Differential evolution of cognitive impairment in non-demented older persons: results from the Kungsholmen Project. Am J Psychiatry. 2002;59:436-442.
20.
Tian J, Bucks RS, Haworth J, et al.Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful. J Neurol Neurosurg Psychiatry. 2003;74:413-414.
21.
Karlawish JH, Clark CM.Diagnostic evaluation of elderly patients with mild memory problems. Ann Intern Med. 2003; 138(5):411-419.
22.
Wolf H, Jelic V, Gertz HJ, et al.A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol Scand. 2003;179(suppl):52-76.
23.
Rubin EH, Morris JC, Grant EA, et al.Very mild senile dementia of the Alzheimer type-I: clinical assessment. Arch Neurol. 1989;46:379-382.
24.
Masur DM, Sliwinski M, Lipton RB, et al.Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology. 1994;44:1427-1432.
25.
Howieson DB, Dame A, Camicioli R, et al.Cognitive markers preceding Alzheimer’s dementia in the healthy oldest old. J Am Geriatr Soc. 1997;45:584-589.
26.
Wolf H, Grunwald M, Ecke GM, et al.The prognosis of mild cognitive impairment in the elderly. J Neural Transm Suppl. 1998;54:31-50.
27.
Camicioli R, Howieson D, Oken B, et al.Motor slowing precedes cognitive impairment in the oldest old. Neurology. 1998;50:1496-1498.
28.
Maccioni RB, Lavados M, Maccioni CB, et al.Biological markers of Alzheimer’s disease and mild cognitive impairment. Curr Alzheimer Res. 2004;1: 307-314.
29.
Vanderstichele H, De Meyer G, Andreasen N, et al.Amino-truncated β-amyloid-42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment. Clin Chem. 2005;51:1650-1660.
30.
Van Dujin CM.Prospects of genetic research of mild cognitive impairment. J Intern Med. 2004;256:235-239.
31.
Meneses A: 5-HT system and cognition. Neurosci Biobehav Rev. 1999;23:1111-1125.
32.
Bigler ED, Lowry CM, Anderson CV, et al.Dementia, quantitative neuroimaging, and apolipoprotein E genotype. Am J Neuroradiol. 2000;211:857-868.
33.
De Leon MJ, George AE, Golomb J, et al.Frequency of hippocampal-formation atrophy in normal aging and Alzheimer’s disease. Neurobiol Aging. 1997;18:1-11.
34.
Jack CR Jr, Petersen RC, Xu YC, et al.Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999;52:1397-1403.
35.
Jack CR Jr, Petersen RC, Xu YC, et al.Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology. 2000;55:484-489.
36.
Yamaguchi S, Menguro K, Shimada M, et al.Five-year retrospective changes in hippocampal atrophy and cognitive-screening-test performances in very mild Alzheimer’s disease: the Tajiri Project. Neuroradiology. 2002;44:43-48.
37.
Du AT, Schuff N, Amend D, et al.Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2001;71:441-447.
38.
Kantarci K, Xu YC, Shiung MM, et al.Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer’s disease. Dement Geriatr Cogn Disord. 2002;14:198-207.
39.
Kantarci K, Jack CR Jr.Neuroimaging in Alzheimer’s disease: an evidence-based review. Neuroimaging Clin N Am. 2003;13:197-209.
40.
Kantarci K, Jack CR Jr, Xu YC, et al.Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease: a 1H MRS study. Neurology. 2000;55:210-217.
41.
Parnetti L, Lowenthal D, Presciutti O, et al.H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPET in normal aging, age-associated memory impairment, and probable Alzheimer’s disease. J Am Geriatr Soc. 1996;44:209-211.
42.
De Santi S, de Leon MJ, Rusinek H, et al.Hippocampal formation, glucose metabolism, and volume losses in MCI and AD. Neurobiol Aging. 2001;22:529-539.
43.
De Leon MJ, Convit A, Wolf OT, et al.Prediction of cognitive decline in normal elderly subjects with 2-(18F)fluoro- 2-deoxi-D-glucose/positron-emission tomography (FDG/PET). Proc Natl Acad Sci U S A. 2001;98:10966-10971.
44.
Arnaiz E, Jelic V, Almkvist O, et al.Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport. 2001;12: 851-855.
45.
Kogure D, Matsuda H, Ohnishi T, et al.Longitudinal evaluation of early Alzheimer’s disease using brain per-fusion SPECT. J Nucl Med. 2000;41:1155-1562.
46.
Okamura N, Shinkawa M, Arai H, et al.Prediction of progression in patients with mild cognitive impairment using IMP-SPECT. Nippon Ronen Igakkai Zasshi. 2000;37:974-978.
47.
Ishiwatta A, Kitamura S, Nagazumi A, et al.Cerebral blood flow of patients with age-associated memory impairment and the early stage of Alzheimer’s disease: a study by SPECT using the ARG method. Nippon Ika Daigaku Zasshi. 1998; 65:140-147.
48.
Johson KA, Jones K, Holman BL, et al.Preclinical prediction of Alzheimer’s disease using SPECT. Neurology. 1998;50: 1563-1572.
49.
Chételat G, Desgranges B, de la Sayette V, et al.Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer’s disease?Neurology. 2003;60: 1374-1377.
50.
Marquis S, Moore M, Howieson DB, et al.Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol. 2002;59:601-606.
51.
Folstein MF, Folstein SE, McHugh PR.Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
52.
Petersen RC, Smith GE, Waring SC, et al.Aging memory and mild cognitive impairment. Int Psychogeriatr. 1997;9: 65-69.
53.
Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameters for diagnosis and evaluation of dementia (summary statement). Neurology. 1994;44:2203-2206.
54.
Busse A, Bischkopf J, Riedel-Heller SG, et al.Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria—results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br J Psychiatry. 2003;182: 449-454.
55.
Storand M, Grant EA, Miller JP, et al.Rates of progression in mild cognitive impairment and early Alzheimer’s disease. Neurology. 2002;59:1034-1041.
56.
Petersen RC, Morris JC.Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol. 2005;62:1160-1163.
57.
Gauthier S, Touchon J.Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol. 2005; 62:1164-1166.
58.
Knopman DS, Boeve BF, Petersen RC.Essentials of proper diagnosis of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin Proc. 2003;78:1290-1308.
59.
Tuokko H, Frerichs R, Graham J, et al.Five-year follow-up of cognitive impairment with no dementia. Arch Neurol. 2003;60:577-582.
60.
Collie A, Maruff P, Shafiq-Antonacci R, et al.Memory decline in healthy older people: implications for identifying mild cognitive impairment. Neurology. 2001;56: 1533-1538.
61.
Luis CA, Barker W, Loewenstein DA, et al.Conversion to dementia among two groups with cognitive impairment. Dement Geriatr Cogn Disord. 2004;18:307-313.
62.
Visser PJ, Verhey FR, Scheltens P, et al.Diagnostic accuracy of the pre-clinical AD scale (PAS) in cognitively mildly impaired subjects. J Neurol. 2002;249: 312-319.
63.
Visser PJ, Verhey FR, Ponds RW, et al.Diagnosis of pre-clinical Alzheimer’s disease in a clinical setting. Int Psychogeriatr. 2001;13:411-423.
64.
Perry RJ, Watson P, Hodges JR.The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer’s disease: relationship to episodic and semantic memory impairment. Neuropsychologia. 2000;38:252-271.
65.
Arnaiz E, Almkvist O.Neuropsychological features of mild cognitive impairment and pre-clinical Alzheimer’s disease. Acta Neurol Scand. 2003;179(suppl):34-41.
66.
Cullum C, Huppert FA, McGee M, et al.Decline across different domains of cognitive functioning in normal aging: results of a longitudinal population-based study using CAMCOG. Int Geriatr Psychiatry. 2000;15:853-862.
67.
De Jager CA, Hogervorst E, Combrinck M, et al.Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment, and Alzheimer’s disease. Psychol Med. 2003;33: 1039-1050.
68.
Ready RE, Ott BR, Grace J, et al.Apathy and executive dysfunction in mild cognitive impairment and Alzheimer’s disease. Am J Geriatr Psychiatry. 2003;11:222-228.
69.
Boyle PA, Malloy PF, Salloway S, et al.Executive dysfunction and apathy predict functional impairment in Alzheimer’s disease. Am J Geriatr Psychiatry. 2003;11: 214-221.
70.
Grundman M, Jack CR, Petersen RC, et al.Hippocampal volume is associated with memory, but not non-memory, cognitive performance in patients with mild cognitive impairment. J Mol Neurosci. 2003;20:241-248.
71.
Chételat G, Desgranges B, de la Sayette V, et al.Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain. 2003;126:1955-1967.
72.
Lambon Ralph MA, Patterson K, Graham N, et al.Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer’s disease: a cross-sectional and longitudinal study of 55 cases. Brain. 2003;126: 2350-2362.
73.
Ingles JL, Fisk JD, Merry HR, et al.Five-year outcomes for dementia defined solely by neuropsychological-test performance. Neuroepidemiology. 2003;22:172-178.
